Close
Close

Vertex Pharmaceuticals Incorporated - Cystic Fibrosis

Partner

Not provided

Rare Disease

Cystic Fibrosis

Sponsor

Vertex Pharmaceuticals Incorporated

Access Program Information

To provide TEZ/IVA combination therapy to CF patients who are 12 years of age and older who completed Vertex TEZ/IVA combination therapy clinical studies (NCT02565914 or NCT03150719). To provide TEZ/IVA combination therapy to CF patients in critical need who are 12 years of age and older, homozygous for F508del.

Contact

Contact: Medical Information (617-341-6777)

Locations

Free Newsletter